For example, miglustat (N-butyldeoxynojirimycin, NB-DNJ), is an immunosugar inhibitor of glucosylceramide synthase that reduces the substrate accumulation due to the mutations of glucocerebrosidase in Gaucher disease (Pastores et al., 2009). This evidence concerns the gene GBA1 and Gaucher disease.